Louise Batchelor
Group Chief Marketing and Communications Officer
Replay available
VolitionRX Limited (VNRX) Q2 2025 Earnings Call
VolitionRX Limited (AMEX: VNRX) Q2 2025 earnings conference call, held 2025-08-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Terry Hughes
Chief Financial Officer
Dr. Andrew Retter
Chief Medical Officer
Cameron Reynolds
Group Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Volitionrx Limited.
Replay transcript excerpt
WEBVTT 00:00:00.537 -- 00:00:03.000 Good morning, ladies and gentlemen, and thank you for standing by. 00:00:03.000 -- 00:00:08.065 Welcome to VolitionRx Limited's second quarter 2025 00:00:08.065 -- 00:00:12.750 earnings conference call. During today's presentation, all parties will be in a listen-only 00:00:12.750 -- 00:00:17.615 mode. Following the presentation, the conference call will be open for questions. 00:00:17.615 -- 00:00:22.700 If you have a question, please press the star key followed by the number 1 on your touch-tone 00:00:22.700 -- 00:00:27.766 phone. If you'd like to withdraw your question, please press the star key 00:00:27.766 -- 00:00:32.883 followed by the number 2. If you're using a speaker equipment, please lift the handset 00:00:32.883 -- 00:00:37.930 before making your selections. This conference is being recorded today, August 15th, 00:00:37.930 -- 00:00:43.237 2025. I'd now like to turn the call over to Louise Batchelor, 00:00:43.237 -- 00:00:46.341 Group Chief Marketing and Communications Officer. 00:00:46.341 -- 00:00:48.762 Please go ahead. 00:00:48.945 -- 00:00:54.993 Thank you, and welcome everyone to today's earnings conference call for VolitionRx Ltd. 00:00:54.993 -- 00:00:59.278 Before we begin, I'd like to remind everyone that some of the information discussed on 00:00:59.278 -- 00:01:04.585 this conference call will include forward-looking statements covered under the safe harbor 00:01:04.585 -- 00:01:09.672 provisions of the Private Securities Litigation Reform Act of 1995. 00:01:09.672 -- 00:01:14.818 These statements are based on our beliefs as well as assumptions we have used based 00:01:14.818 -- 00:01:18.223 upon information currently available to us. 00:01:18.223 -- 00:01:23.229 Because these statements reflect our current...